Cardiology (all articles)
M-A: Data from randomized trials showed nonfatal myocardial infarction cannot be established as a good surrogate for all-cause and cardiovascular mortality.
26 Oct, 2021 | 01:36h | UTCAssessment of Nonfatal Myocardial Infarction as a Surrogate for All-Cause and Cardiovascular Mortality in Treatment or Prevention of Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials – JAMA Internal Medicine (free for a limited period)
Editorial: Nonfatal Myocardial Infarction—Poor Surrogate for Mortality – JAMA Internal Medicine (free for a limited period)
Review: Cardiac involvement in the long-term implications of COVID-19.
24 Oct, 2021 | 23:59h | UTCCardiac involvement in the long-term implications of COVID-19 – Nature Reviews Cardiology
2021 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19.
24 Oct, 2021 | 23:49h | UTCCommentary: CPR on a COVID Patient: Not a Moment to Waste Looking for PPE: Updated AHA guidance says resuscitation should not be delayed by mask availability – MedPage Today (free registration required)
Commentary on Twitter (thread – click for more)
(1/2) NEW! The AHA has published its 2021 interim CPR guidance for #HCPs who treat cardiac arrest patients with suspected or confirmed #COVID19. The paper in @CircOutcomes is an update to the 2020 Interim CPR Guidance: https://t.co/tuTwWkE0dL. pic.twitter.com/B1el7dCKJM
— AHA CPR & First Aid (@HeartCPR) October 13, 2021
RCT: In comatose survivors of out-of-hospital cardiac arrest, there was no difference in mortality and neurologic outcomes with mild (target temperature of 34 °C) vs. moderate therapeutic hypothermia (target temperature of 31 °C).
24 Oct, 2021 | 23:46h | UTCEffect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The CAPITAL CHILL Randomized Clinical Trial – JAMA (free for a limited period)
Related:
Study commentary: a history of hypothermia for cardiac arrest, 2002-2021 (RIP).
Commentary on Twitter
therapeutic hypothermia after cardiac arrest is a nonbeneficial form of iatrogenesis that prolongs ICU length of stay (findings entirely consistent with TTM & TTM2). currently it should not be performed outside the context of an RCT. https://t.co/GZbpgHXWoD https://t.co/kRwRpLz6hV
— 𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊 (@PulmCrit) October 20, 2021
Middle-aged and older women are being diagnosed with Takotsubo Syndrome more frequently, up to 10 times more often, than younger women or men of any age.
24 Oct, 2021 | 23:43h | UTCNews release: Broken heart syndrome is on the rise, especially among older women – American Heart Association
Commentary: ‘Broken heart’ syndrome is on the rise in women – Cedars-Sinai Medical Center
Related:
International Expert Consensus Document on Takotsubo Syndrome
International Registry: 16.6% of Patients with Takotsubo Syndrome Have Underlying Malignancy
Systematic Review: Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome
Cohort Study: Hospital Readmission Following Takotsubo Syndrome
M-A: Diagnostic accuracy of handheld cardiac ultrasound device for assessment of left ventricular structure and function.
22 Oct, 2021 | 10:15h | UTC
Cohort Study: Hypertensive disorders of pregnancy are associated with a 6-fold or higher increased risk of chronic hypertension in the first years following delivery.
21 Oct, 2021 | 09:51h | UTCEditorial: Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION
Commentary on Twitter
Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study@escardio #EHJ #cardiotwitterhttps://t.co/OnJRP94W6v pic.twitter.com/N3dLNTD5XU
— EHJ Editor-in-Chief (@ehj_ed) October 17, 2021
Review: Athletes and Hypertension.
20 Oct, 2021 | 09:52h | UTCAthletes and Hypertension – Current Cardiology Reports
Things We Do for No Reason: fluid restriction for the management of acute decompensated heart failure in patients with reduced ejection fraction.
20 Oct, 2021 | 10:00h | UTCThings We Do for No Reason™: Fluid Restriction for the Management of Acute Decompensated Heart Failure in Patients With Reduced Ejection Fraction – Journal of Hospital Medicine (free for a limited period)
Commentary on Twitter
🚨 Today’s Things We Do for No Reason ™️ from @JHospMedicine: Why do we think fluid restriction is important in managing ADHF? What’s the alternative? 💓
📢 Sound off in the replies why you do or don’t follow this practice. 👀#HeartFailure #ADHFhttps://t.co/QayZdqqNSd
— Society of Hospital Medicine (@SocietyHospMed) October 19, 2021
Another observational study suggests Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants.
19 Oct, 2021 | 09:47h | UTCRivaroxaban Is Associated with Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants: A Nationwide Propensity Score–Weighted Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Rivaroxaban Again Linked to More Bleeding vs Other DOACs – TCTMD
Commentary on Twitter
A new study from @uni_iceland and @Landspitali finds that #Rivaroxaban is associated with a higher risk of GI bleeding compared to other direct oral anticoagulants. https://t.co/2J451CN5dD #afib #bleedingrisk #DOAC pic.twitter.com/Q6VSv5Taqg
— Annals of Int Med (@AnnalsofIM) October 13, 2021
Guideline: Management of anticoagulants and antiplatelet agents in cutaneous surgery.
19 Oct, 2021 | 09:50h | UTC
Systematic Review: Calcium channel blockers versus other classes of drugs for hypertension – “there is moderate certainty evidence that diuretics reduce major cardiovascular events and congestive heart failure more than CCBs”.
19 Oct, 2021 | 08:56h | UTCSummary: Calcium channel blockers versus other classes of drugs for hypertension – Cochrane Library
Original Study: Calcium channel blockers versus other classes of drugs for hypertension – Cochrane Library
Commentary on Twitter
How do calcium channel blockers compare to other #antihypertensive drugs for #hypertension?💊
Our @CochraneLibrary systematic review looks at evidence from 23 RCTs involving 153,849 participants with #highbloodpressure
👉🏾https://t.co/dDLCY1RoOT#SystematicReviews #SysRev pic.twitter.com/zJ4JNRRf0L
— Cochrane Hypertension (@CochraneHTN) October 17, 2021
Preoperative hypertension: perioperative implications and management.
19 Oct, 2021 | 08:51h | UTCPreoperative hypertension: perioperative implications and management – BJA Education
Guidelines for anesthesiologists on patient blood management in cardiac surgery.
17 Oct, 2021 | 21:22h | UTC
Commentary on Twitter
Please check out editorial on patient #blood management in #cardiacsurgery, a collaboration between Society of Thoracic Surgeons, Society of Cardiovascular Anestheisologists and SABM, AmSECT. https://t.co/HHA8SjxNot pic.twitter.com/DAj2TrGYC3
— Jiapeng Huang (@jiapenghuang) September 24, 2021
Statins linked to reduced risk of death from COVID-19 in major population study – “Randomized studies will be needed to ascertain whether there is a causal relationship, note the researchers”.
15 Oct, 2021 | 02:47h | UTCNews release: Statins linked to reduced risk of death from COVID-19 in major population study – Karolinska Institutet
Original study: HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study – PLOS Medicine
Commentaries:
Expert reaction to study looking at statins and risk of death from COVID-19 – Science Media Centre
People taking statins less likely to die from Covid, study suggests – The Guardian
FDA issues food industry guidance for reduction of sodium in processed and packaged foods.
15 Oct, 2021 | 02:29h | UTCGuidance for Industry: Voluntary Sodium Reduction Goals – U.S. Food & Drug Administration
Commentaries:
FDA Issues New Guidance on Sodium Targets for Food Industry – TCTMD
Reducing Sodium Intake in the US: Healthier Lives, Healthier Future – JAMA
FDA Reduces Recommended Salt Levels in Americans’ Food – HealthDay
FDA guidance to food industry aims to reduce sodium consumption – American Heart Association
New FDA guidance aims to drastically cut salt in food supply – NBC News
Former CDC director: Low sodium salt could save millions of lives.
15 Oct, 2021 | 02:27h | UTCFormer CDC director: Low sodium salt could save millions of lives – CNN
Related:
Is salt good for you after all? The evidence says no.
Systematic Review: Altered dietary salt intake for people with chronic kidney disease.
New WHO benchmarks help countries reduce salt intake and save lives.
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels
Systematic Review: There is not enough evidence from randomized trials to inform about the effects of additional antihypertensive drugs in patients with hypertension‐induced left ventricular hypertrophy.
15 Oct, 2021 | 02:20h | UTCPharmacotherapy for hypertension‐induced left ventricular hypertrophy – Cochrane Library
Commentary on Twitter
What are the effects of added #antihypertensive drug therapy on morbidity/mortality of people with #LVH and #hypertension? 💊
Our @CochraneLibrary @CochraneHTN systematic review looks at evidence from 3 RCTs w/ 930 participants with #highbloodpressure
👉🏾https://t.co/d3dakCPW0B pic.twitter.com/ppCqKBU7K0
— Cochrane Hypertension (@CochraneHTN) October 11, 2021
Meta-analysis of cohort studies: High intake of fatty acid in nuts, seeds and plant oils linked to lower risk of death.
15 Oct, 2021 | 02:22h | UTCNews release: High intake of fatty acid in nuts, seeds and plant oils linked to lower risk of death – The BMJ
Commentaries:
Current evidence on dietary intakes of fatty acids and mortality – The BMJ
Commentary on Twitter
NEW research: A high intake of alpha linolenic acid, found mainly in nuts, seeds, and plant oils, is associated with a lower risk of death from all causes, and specifically from diseases of the heart and blood vessels, finds a study https://t.co/HGvg8dBUUN
— The BMJ (@bmj_latest) October 14, 2021
Trends in use and outcomes of same-day discharge following elective percutaneous coronary intervention.
15 Oct, 2021 | 02:15h | UTCTrends in Use and Outcomes of Same-Day Discharge Following Elective Percutaneous Coronary Intervention – JACC: Cardiovascular Interventions (link to abstract – $ for full-text)
Commentaries:
Trends in Same-Day Discharge for Elective PCI – American College of Cardiology
M-A: Predictors of permanent pacemaker implantation in patients undergoing transcatheter aortic valve replacement.
15 Oct, 2021 | 02:19h | UTC
Commentary on Twitter
Meta-analysis of 78 studies identifies key predictors of pacemaker implantation after TAVR. https://t.co/EYFo1jWj5m #AHAJournals @vakasullah @fischman_david @TJUHospital @TJHeartFellows pic.twitter.com/eu7WbUoTGY
— JAHA (@JAHA_AHA) July 22, 2021
Cohort study: Among women with congenital Long QT, progestin oral contraceptives were linked to a 2.8-fold increased risk of cardiovascular events in those not receiving B-blocker therapy.
15 Oct, 2021 | 02:17h | UTCUse of oral contraceptives in women with congenital long QT syndrome – Heart Rhythm (link to abstract – $ for full-text)
Commentary: Progestin OCs Triple CV Events in Women With Congenital Long QT – TCTMD
Podcast with Dr Walter Willett: CardioNutrition – Why are findings from prospective, epidemiologic cohort studies important in informing dietary recommendations?
14 Oct, 2021 | 09:49h | UTC
Commentary on Twitter
In this episode of CardioNutrition, @DrOstfeld and Dr. Walter Willett discuss why findings from prospective, epidemiologic cohort studies are important in informing dietary recommendations. Learn more here: https://t.co/IfIgauGhV9 #cvPrev #cvLipids pic.twitter.com/flet8ZTwFe
— American College of Cardiology (@ACCinTouch) October 8, 2021
M-A: Outcomes after transcatheter aortic valve replacement in bicuspid versus tricuspid anatomy – device success and 1-year survival rates are similar, but patients with bicuspid valves have a higher risk for periprocedural complications.
14 Oct, 2021 | 09:51h | UTC
USPSTF draft statement revises previous guidance and now recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults aged 60 years or older.
13 Oct, 2021 | 01:36h | UTCCommentaries:
Advice shifting on aspirin use for preventing heart attacks – Associated Press
Taking aspirin to prevent heart attack may cause more harm than good, task force says – NPR
Related Randomized Trials:
Randomized Trial: Aspirin for Primary Prevention of Cardiovascular Disease
Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes
Randomized Trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
Related Meta-Analysis:
Meta-Analysis: Efficacy and Safety of Aspirin for Primary Prevention of Cardiovascular Events
Related Opinions:
Aspirin for Primary Prevention: Is This the End of the Road?
Evidence evolving on aspirin as prevention – ACP Internist
Commentary on Twitter
Low Dose Aspirin in the Primary Prevention of Cardiovascular Disease: #USPSTF recommends individualized decision making between 50 and 59 years, and against aspirin use in 60 years+. What a difference a few years can make, with more data and evidence. https://t.co/3nC3jpjTDq pic.twitter.com/SN8K3Z9XJj
— Muin J. Khoury (@MuinJKhoury) October 12, 2021


